Study of DF1001 in Patients With Advanced Solid Tumors

NCT04143711 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: DF1001
DRUG: Nivolumab
DRUG: Nab paclitaxel
DRUG: Sacituzumab Govitecan-hziy

Sponsor

Dragonfly Therapeutics